Information Library
Results for: Cost control/reduction - High-quality studies - Late Phase
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Population PK/PD - Modeling and Simulation Optimization Tools
Brochure — February 11, 2011
Population pharmacokinetic/ pharmacodynamic (PK/PD) modeling and simulation, available from Quintiles, is now endorsed by the FDA as often being instrumental in drug approval and labeling. -
New FDA Guidance on Antidiabetic Therapies
White Paper — December 11, 2009
Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program. -
Early phase strategies
Hear from the Experts — June 15, 2009
Web cast about Early Phase Strategies. -
Antibiotic Safety Assessment
Case Study — March 25, 2009
A major pharmaceutical company presented Quintiles with a pressing challenge – to collect extensive amounts of Phase IV data in compressed time windows because the treatment conditions were subject to seasonal variants.
Page 1 of 1 (4 results)
